Impressed by the spend on exploration - 'Expenditure on exploration and evaluation' of a shade of grey under 9 million dollars! But so glad that PFS is done and dusted.
Two nice announcements and two modest green days - I'm really confident about our company now.
- Forums
- ASX - By Stock
- FFX
- Ann: 30 June 2018 Half-Year Financial Report
Ann: 30 June 2018 Half-Year Financial Report, page-8
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add FFX (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online